Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 21478494)

1.

Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.

Nan H, Xu M, Zhang J, Zhang M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Rimm EB, Curhan G, Song Y, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J.

Hum Mol Genet. 2011 Jul 1;20(13):2673-9. doi: 10.1093/hmg/ddr154. Epub 2011 Apr 9.

2.

Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.

Falchi M, Bataille V, Hayward NK, Duffy DL, Bishop JA, Pastinen T, Cervino A, Zhao ZZ, Deloukas P, Soranzo N, Elder DE, Barrett JH, Martin NG, Bishop DT, Montgomery GW, Spector TD.

Nat Genet. 2009 Aug;41(8):915-9. doi: 10.1038/ng.410. Epub 2009 Jul 5.

3.

Variants at the 9p21 locus and melanoma risk.

Maccioni L, Rachakonda PS, Bermejo JL, Planelles D, Requena C, Hemminki K, Nagore E, Kumar R.

BMC Cancer. 2013 Jul 2;13:325. doi: 10.1186/1471-2407-13-325.

4.

Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.

Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Curhan G, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J.

Hum Mol Genet. 2011 Sep 15;20(18):3718-24. doi: 10.1093/hmg/ddr287. Epub 2011 Jun 23.

5.

A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.

Han J, Qureshi AA, Nan H, Zhang J, Song Y, Guo Q, Hunter DJ.

Cancer Res. 2011 Mar 1;71(5):1533-9. doi: 10.1158/0008-5472.CAN-10-1818. Epub 2011 Jan 26.

6.

An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.

Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos Santos Silva I, Swerdlow AJ, Bishop DT, Newton Bishop JA.

J Invest Dermatol. 2004 Feb;122(2):429-32.

7.

Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.

Carli P, Massi D, Santucci M, Biggeri A, Giannotti B.

J Am Acad Dermatol. 1999 Apr;40(4):549-57.

PMID:
10188672
8.

IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Duffy DL, Iles MM, Glass D, Zhu G, Barrett JH, Höiom V, Zhao ZZ, Sturm RA, Soranzo N, Hammond C, Kvaskoff M, Whiteman DC, Mangino M, Hansson J, Newton-Bishop JA; GenoMEL, Bataille V, Hayward NK, Martin NG, Bishop DT, Spector TD, Montgomery GW.

Am J Hum Genet. 2010 Jul 9;87(1):6-16. doi: 10.1016/j.ajhg.2010.05.017. Epub 2010 Jun 17.

9.

Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.

Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA.

J Invest Dermatol. 2008 Aug;128(8):2122-5. doi: 10.1038/jid.2008.51. Epub 2008 Mar 13. No abstract available.

10.

Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.

Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F.

J Natl Cancer Inst. 2004 May 19;96(10):785-95.

11.

Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.

Liu H, Wang LE, Liu Z, Chen WV, Amos CI, Lee JE; Q-MEGA and AMFS Investigators; GenoMEL Investigators, Iles MM, Law MH, Barrett JH, Montgomery GW, Taylor JC, MacGregor S, Cust AE, Newton Bishop JA, Hayward NK, Bishop DT, Mann GJ, Affleck P, Wei Q.

Carcinogenesis. 2013 Apr;34(4):885-92. doi: 10.1093/carcin/bgs407. Epub 2013 Jan 4.

12.

No Evidence for BRAF as a melanoma/nevus susceptibility gene.

Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, dos Santos Silva I, Beswick S, Bishop DT, Newton Bishop JA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):913-8.

13.

On the interplay of telomeres, nevi and the risk of melanoma.

Bodelon C, Pfeiffer RM, Bollati V, Debbache J, Calista D, Ghiorzo P, Fargnoli MC, Bianchi-Scarra G, Peris K, Hoxha M, Hutchinson A, Burdette L, Burke L, Fang S, Tucker MA, Goldstein AM, Lee JE, Wei Q, Savage SA, Yang XR, Amos C, Landi MT.

PLoS One. 2012;7(12):e52466. doi: 10.1371/journal.pone.0052466. Epub 2012 Dec 27.

14.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773
15.

Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I, Nicolaou V, Spyrou G, Evangelou E, Roehr JT, Kodela E, Katsambas A, Tsao H, Ioannidis JP, Bertram L, Stratigos AJ.

J Natl Cancer Inst. 2011 Aug 17;103(16):1227-35. doi: 10.1093/jnci/djr219. Epub 2011 Jun 21. Review.

16.

Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.

Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS.

Ophthalmology. 2007 Apr;114(4):774-9. Epub 2007 Jan 3.

PMID:
17207529
17.

Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG, Hayward NK, Duffy DL.

Twin Res Hum Genet. 2011 Oct;14(5):422-32. doi: 10.1375/twin.14.5.422.

18.

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.

Bishop JA, Wachsmuth RC, Harland M, Bataille V, Pinney E, MacK P, Baglietto L, Cuzick J, Bishop DT.

J Invest Dermatol. 2000 Jan;114(1):28-33.

19.

A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant association with cutaneous melanoma in Southern Italian population.

Capasso M, Ayala F, Russo R, Avvisati RA, Asci R, Iolascon A.

J Cancer Res Clin Oncol. 2009 Dec;135(12):1799-807. doi: 10.1007/s00432-009-0628-y. Epub 2009 Jun 26.

PMID:
19557432
20.

The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.

Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, Bechara FG.

Cell Tissue Res. 2012 Oct;350(1):119-26. doi: 10.1007/s00441-012-1446-0. Epub 2012 Jun 17.

PMID:
22706980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk